The impact of GLP-1 receptor agonist shortages on glycaemic Control: Findings from an Australian specialist diabetes clinic.
Natalie Nanayakkara; Michael Lh Huang; Alicia J Jenkins; Neale D Cohen
Abstract
There have been shortages of glucagon-like peptide-1 receptor agonists (GLP-1 RA) for type 2 diabetes (T2D) care. Analyses of data from 811 T2D adults at an Australian specialist diabetes clinic (1/2019-10/2023) who received ≥ 2 GLP-1 RA prescriptions before and during the shortage showed median HbA1c levels significantly increased by 0.3 %.
| Journal | DIABETES RESEARCH AND CLINICAL PRACTICE |
| ISSN | 1872-8227 |
| Published | 07 Jun 2024 |
| Volume | 213 |
| Issue | |
| Pages | 111740 |
| DOI | 10.1016/j.diabres.2024.111740 |
| Type | Journal Article |
| Sponsorship |
